Medicalsystem Biotechnology Co (SZSE:300439) 3-Year EBITDA Growth Rate : -9.40% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Medicalsystem Biotechnology Co 3-Year EBITDA Growth Rate?

Medicalsystem Biotechnology Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.23.

During the past 12 months, Medicalsystem Biotechnology Co's average EBITDA Per Share Growth Rate was 35.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Medicalsystem Biotechnology Co was 40.20% per year. The lowest was -10.80% per year. And the median was 14.15% per year.

Competitive Comparison of Medicalsystem Biotechnology Co's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Medicalsystem Biotechnology Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicalsystem Biotechnology Co's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medicalsystem Biotechnology Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Medicalsystem Biotechnology Co's 3-Year EBITDA Growth Rate falls into.

Medicalsystem Biotechnology Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Medicalsystem Biotechnology Co (SZSE:300439) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Medicalsystem Biotechnology Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Medicalsystem Biotechnology Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicalsystem Biotechnology Co (SZSE:300439) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medicalsystem Biotechnology Co Ltd (SZSE:300439) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 299 Qiming South Road, Yinzhou District, Zhejiang Province, Ningbo City, CHN, 315104

Website

http://www.nbmedicalsystem.com

Medicalsystem Biotechnology Co Ltd is engaged in research and development, manufacture and distribution of diagnostic products. It provides in-vitro biochemical diagnostic reagents to healthcare facilities.

Executives

Zou Bing De	Director
Xiong Hui Ping	Secretary Dong
Zhuo Hong Ye	Director
Wu Li Shan	Supervisors
Fang Liang	Executives
Zou Ji Hua	Directors, executives
Wo Yan Bo	Executives

Medicalsystem Biotechnology Co (SZSE:300439) Headlines

No Headlines